Although recently approved therapies can increase progression - free
survival by a few months, «we think this novel screening system has the potential to uncover new, more effective medications that could be targeted more specifically at a patient's cancer,» Lengyel said.
Not exact matches
«The current options for maintenance therapy in the EU are bevacizumab, which can only be given once and improves progression - free
survival by just a
few months, and the PARP inhibitor olaparib, which is only approved in patients with a germline BRCA mutation (about 10 - 15 % of ovarian cancer patients).
There is no cure, and only one drug modestly extends
survival by only a
few months.
Only a
few studies have evaluated treatment of this disease, and the most successful treatment (to date) that we know of involves a relatively invasive surgery to remove the sac around the heart followed
by a course of chemotherapy, leading to
survival times averaging about 6
months.
ARK:
Survival Evolved has received a slew of updates and additions to the pre-release version
by developer Studio Wildcard over the last
few months.